Last Update 18 Aug 26
Fair value Increased 5.88%CR: Acquisitions And Index Removals Will Shape Balanced 2026 Earnings Outlook
Analysts have modestly lifted their price target on Crane to $238 from $224.78, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margins, and a higher future P/E multiple.
What’s in the News for Crane
- Crane raised its full year 2026 earnings guidance, with total sales now expected to grow in the mid 20% range, compared with prior guidance of low to mid 20%. This change is driven by acquisitions. Source: Company guidance.
- Crane was removed from the Russell 1000 Defensive Index. Source: Index constituent changes.
- Crane was also removed from the Russell 1000 Value Defensive Index. Source: Index constituent changes.
Valuation Changes for Crane
- Fair Value has risen slightly, with the updated estimate moving to $238.00 from $224.78.
- Discount Rate has edged higher to 8.60% from 8.52%.
- Revenue Growth assumption has been reduced, now set at 8.76% compared with 10.13% previously.
- Net Profit Margin expectation has been trimmed slightly to 16.02% from 16.38%.
- Future P/E multiple has risen modestly to 33.09x from 31.15x.
Key Takeaways
- Expansion into advanced sensing, fluid control, and resilient process flow segments supports sustained revenue growth, margin expansion, and durable earnings in infrastructure and automation markets.
- Strong exposure to aerospace, nuclear, and environmental sustainability end-markets, combined with disciplined pricing and acquisitions, underpins lasting competitive advantage and profitability.
- Exposure to weak markets, integration risks, strong competitors, and ongoing cost pressures threaten revenue growth, profitability, and earnings stability.
Catalysts
About Crane- Manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally.
- Crane's recent acquisition of PSI (Druck, Panametrics, Reuter-Stokes) positions the company to capture rising demand for advanced sensing and fluid control in both aerospace and process industries, directly benefiting from infrastructure modernization and growing automation-supporting sustained revenue and future margin expansion.
- Accelerating global investment in nuclear energy-including plant restarts and new small modular reactor projects-will enhance demand for Reuter-Stokes' radiation sensing technologies, expanding Crane's exposure to long-cycle, mission-critical infrastructure markets and potentially driving above-market long-term growth.
- Robust and growing aftermarket and backlog in Aerospace & Electronics, with strength across defense (air defense, radar, power conversion programs) and commercial aerospace (Boeing production ramp, widebody/composite aircraft, international platforms like COMAC), indicates multi-year visibility for elevated core sales and supports durable earnings growth.
- Continuous shift of the Process Flow Technologies portfolio into higher-growth, resilient segments such as water/wastewater management, cryogenics for space launch, and biopharma (as evidenced by strong order books and recent wins) leverages secular tailwinds around resource efficiency and environmental sustainability, driving revenue growth and margin stability.
- Consistent execution of value-based pricing, targeted bolt-on acquisitions, and operational productivity (offsetting tariff and inflation headwinds) positions Crane to further expand operating leverage and net margins over the coming years, enhancing EPS and return on capital.
Crane Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Crane's revenue will grow by 8.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 13.0% today to 16.0% in 3 years time.
- Analysts expect earnings to reach $534.2 million (and earnings per share of $8.94) by about August 2029, up from $336.1 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $588.2 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 33.3x on those 2029 earnings, down from 37.6x today. This future PE is greater than the current PE for the US Machinery industry at 27.6x.
- Analysts expect the number of shares outstanding to grow by 0.35% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.6%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent weakness and project delays in the European chemical sector and ongoing reductions in customer CapEx could dampen Process Flow Technologies (PFT) growth, leading to lower revenue contribution and increased earnings volatility.
- The integration of newly acquired businesses (such as PSI/ Druck, Panametrics, and Reuter-Stokes) presents execution risks; if expected margin improvement or synergies do not materialize, net margins and ROIC targets could be negatively impacted.
- Exposure to cyclical end-markets (e.g., aerospace, defense, chemical) introduces earnings volatility, especially if macroeconomic conditions worsen or key customers delay/cancel orders-heightening downside risk to overall earnings.
- Competition from larger, technologically advanced players in the industrial automation and sensors segment (e.g., ABB and Emerson against Panametrics), could limit Crane's ability to gain or defend market share, pressuring future revenue growth.
- Ongoing or new tariffs and input cost inflation require continuous price/cost actions; failure to effectively offset these increases, or customer price resistance in a sluggish demand environment, may erode operating margins over time.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $238.0 for Crane based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $253.0, and the most bearish reporting a price target of just $192.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $3.3 billion, earnings will come to $534.2 million, and it would be trading on a PE ratio of 33.3x, assuming you use a discount rate of 8.6%.
- Given the current share price of $218.59, the analyst price target of $238.0 is 8.2% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Crane?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.